Oncology Financial Navigator Ensures Vital Care Access, Eases Economic Burden
October 13th 2023According to the National Cancer Institute, in the year following a cancer diagnosis, the average cost of medical care plus medication exceeds $42,000, with some treatments having a price tag of more than $1 million.
Read More
ASRM 2023: Integrating Advances and Addressing Challenges in Reproductive Medicine
October 13th 2023The American Society of Reproductive Medicine (ASRM) 2023 Scientific Congress & Expo in New Orleans will focus on the latest advancements and challenges in reproductive health, including new treatments and technology, evolving legislation, and the importance of professional guidelines.
Read More
Medicare Part A and B premiums are set to increase by $9.80 next year; 20 experts from various specialties and institutions have developed updated brain death guidelines; many Black patients are strongly affected by multiple COVID-19 infections due to a lack of health insurance and health care access.
Read More
Evaluating WHO's Hemophilia Treatment Choices: Patient Safety, Access Challenges
October 12th 2023A commentary questions the characterization of cryoprecipitate, which is not pathogen-reduced, as an alternative modality for treating hemophilia, despite its substantial risk of transmitting blood-borne pathogens to patients.
Read More
Empathy, Support Are Crucial to Help Patients With Methamphetamine-Related Pulmonary Hypertension
October 11th 2023With methamphetamines continuing to inflict damage on the Western United States, panelists at the CHEST Annual Meeting 2023 shared sobering statistics and important considerations in treating patients with pulmonary hypertension associated with use of this destructive drug.
Read More
Review Details Strategies for Mitigating Bias in Clinical Algorithms
October 10th 2023Based on the comprehensive findings of a review, investigators outline several crucial policy implications, each designed to address the complex issue of bias mitigation in clinical algorithms effectively.
Read More
Air Pollution, Lung Health, and the Role of the Pulmonologist
October 10th 2023Amid the impacts of climate change, industrial emissions, and environmental disasters, pulmonologists and other clinicians will need to deliver actionable advice on how to reduce the risks to lung health posed by air pollution, according to panelists at the CHEST Annual Meeting 2023.
Read More
Keys to Achieving Equity in Lung Cancer Screening Include Erasing Stigma, Tackling Systemic Barriers
October 9th 2023Increasing lung cancer screening uptake without tailoring outreach and follow-up for underserved populations risks magnifying the existing racial and ethnic disparities in screening, so thoughtful approaches are needed to close the gaps, according to speakers at the CHEST Annual Meeting 2023.
Read More
Avidity Biosciences Gains FDA Orphan Drug Designation for Patients With DMD
October 9th 2023Sarah Boyce, president and CEO at Avidity Biosciences, discusses her leading role at the company, as well as antibody oligonucleotide conjugate drug, AOC 1044, currently in development for Duchenne muscular dystrophy (DMD) with mutations amenable to exon 44 skipping (DMD44).
Read More
Mobile Mammography Unit Increases Breast Cancer Screening Among Latina Patients
October 7th 2023Pinky, a mobile mammography unit from Stony Brook University Hospital Cancer Center on Long Island, increased screening for breast cancer from 9% to 69% among the predominantly Latina population that it serves.
Read More
To Decrease Medical Mistrust in Oncology, We Must Increase Community Inclusivity
October 5th 2023A poster presented at the 40th National Oncology Conference addressed several hot topics in the oncology treatment and research space: addressing medical mistrust in underresourced communities, partnering with trusted organizations to improve health equity, and increasing inclusivity in research.
Read More
Alleged Medicare Fraud: Fresenius Vascular Care Faces Civil Lawsuit for Unnecessary Surgeries
October 5th 2023Fresenius Vascular Care's own research reportedly showed these surgeries not only failed to benefit patients with end-stage renal disease, but also potentially damaged their ability to receive essential dialysis treatment.
Read More
Alcohol Use Not Associated With Lower Odds of Achieving SVR With Hepatitis C Treatment
October 4th 2023The researchers noted that their findings suggest clinicians and policy makers should encourage hepatitis C virus (HCV) treatment in those with unhealthy alcohol consumption or alcohol use disorder (AUD) rather than create barriers to it.
Read More